Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Testicular Neoplasms 30Testicular Germ Cell Tumor 17Prostatic Neoplasms 13Wilms Tumor 12Teratoma 12Ovarian Neoplasms 11Kidney Neoplasms 9Seminoma 8Endodermal Sinus Tumor 8Sarcoma 7Neuroectodermal Tumors, Primitive, Peripheral 7Central Nervous System Neoplasms 7Carcinoma, Embryonal 7Ovarian Germ Cell Cancer 6Carcinoma, Renal Cell 6Urinary Bladder Neoplasms 4Osteosarcoma 4Neuroblastoma 4Neoplasms 4Melanoma 4Medulloblastoma 4Small Cell Lung Carcinoma 3Rhabdoid Tumor 3Retinoblastoma 3Optic Nerve Glioma 3Neoplasms, Germ Cell and Embryonal 3Lung Neoplasms 3Hepatoblastoma 3Breast Neoplasms 3Astrocytoma 3

Interventions

Gemcitabine 9pembrolizumab 7Cisplatin 5enfortumab vedotin 4atezolizumab 4Trastuzumab 4Mitomycin 4Carboplatin 4Sunitinib 3Pemetrexed 3dodecyl maltoside 2cabozantinib 2Water 2Sugammadex 2Standard of Care 2Saline Solution 2Paclitaxel 2Nivolumab 2Neostigmine 2Docetaxel 2Cetuximab 2Bevacizumab 2zidovudine 5'-monophosphate-mannose-albumin conjugate 1vinflunine 1valrubicin 1tucatinib 1tislelizumab 1testosterone 17 beta-cypionate 1temsirolimus 1relatlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Etoposide × Genitourinary × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡